Overview
IPSC market data
Price History
IPSC price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.11 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.63 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -18.9% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.44 – $3.04 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $348.1M · P/B 0.55 · P/S 3.03.
Company News
8-K filing — Century Therapeutics, Inc. (IPSC)SEC EDGAR · Aug 12, 2026, 12:12 PM
Century Therapeutics Q2 EPS $(0.17) Misses $(0.14) EstimateBenzinga · Aug 12, 2026, 12:05 PM
Concentrix Reports Downbeat Q2 Earnings, Joins Nuvectis Pharma, Vishay Intertechnology And Other Big Stocks Moving Lower In Tuesday’s Pre-Market SessionBenzinga · Jun 30, 2026, 12:05 PM
Apogee Enterprises Posts Strong Q1 Earnings, Joins ACADIA Pharmaceuticals, Crocs And Other Big Stocks Moving Higher On FridayBenzinga · Jun 26, 2026, 2:25 PM
Cutaneous Lupus Erythematosus Market to Expand at a CAGR of 8% During the Forecast Period (2026–2036) Amid Emerging Therapies and Increasing Healthcare Investments | DelveInsightGlobenewswire Inc · Jun 22, 2026, 5:15 PM
Lupus Nephritis Clinical Trial Landscape Becomes Increasingly Crowded with 30+ Pharma Companies | DelveInsightGlobenewswire Inc · Jun 10, 2026, 5:15 PM
Century Therapeutics Announces Presentation Of New Preclinical Data At American Diabetes Association Sessions Supporting CNTY-813 Novel Islet Cell Replacement TreatmentBenzinga · Jun 8, 2026, 8:15 PM
Graham, Appian And Other Big Stocks Moving Lower In Monday's Pre-Market SessionBenzinga · Jun 8, 2026, 12:05 PM
A Third Cancer Drug Just Entered the Clinic at an Under-$20-Million CompanyBenzinga · Jun 2, 2026, 2:15 PM
Abercrombie & Fitch Upbeat Q1 Earnings, Joins Digital Turbine, Dycom Industries And Other Big Stocks Moving Higher On WednesdayBenzinga · May 27, 2026, 2:55 PM